India's Richest People 2026 edition · 1 director · Source: Hurun India
- #169 M Satyanarayana Reddy & family ₹21,600 Cr
Revenue · FY 2024
₹1,961.87 Cr
▲ 54% YoY
Net profit · FY 2024
₹189.59 Cr
Net margin 9.7%
EBITDA · FY 2024
₹399.58 Cr
EBITDA margin 20.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.74 Cr
Issued & subscribed
Open charges
₹1,700.8 Cr
Satisfied ₹690.22 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
1,960
Provident fund records
About MSN Life Sciences Private Limited
Data last updated:
MSN Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 October 2005 and has been in existence for over 21 years.
Its director M Satyanarayana Reddy and family are #169 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PTC047655. Its GSTIN is 36AACCV1325N1Z7 (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.74 Cr. It was formerly known as Vijeta Life Sciences Pvt Ltd and Vijeta Life Sciences Private Limited. It is led by directors including Sindhuja Reddy Manne (Whole-Time Director) and Satyanarayana Reddy Manne.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹1,961.87 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹189.59 Cr (net margin 9.7%) and EBITDA of ₹399.58 Cr (EBITDA margin 20.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 22% over five years.
The company has about 1,960 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹1,700.8 Cr and satisfied charges of ₹690.22 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.64 Cr; the latest was in January 2012. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Centrient Pharmaceuticals India Private Limited with revenue of ₹2,240.1 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website msnlabs.com.
Company details
CIN U24239TG2005PTC047655
Registration Number 047655
Incorporation Date 03 October 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Name history
MSN Life Sciences has undergone 2 name changes throughout its history. The company was previously known as Vijeta Life Sciences Pvt Ltd, and Vijeta Life Sciences Private Limited. The current legal name is Msn Life Sciences Private Limited.
| Company Name | Status |
|---|---|
| MSN Life Sciences Private Limited | Current |
| Vijeta Life Sciences Pvt Ltd | Previous |
| Vijeta Life Sciences Private Limited | Previous |
CIN history
MSN Life Sciences has one previous CIN (Corporate Identification Number): U24239AP2005PTC047655. The current CIN is U24239TG2005PTC047655, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005PTC047655 | Current |
| U24239AP2005PTC047655 | Previous |
Key People
Sindhuja Reddy Manne Whole-Time Director Satyanarayana Reddy Manne Director Laxmi Prasuna Manne Director Recognitions & Rankings of MSN Life Sciences
Contact details
MSN Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is msnlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMsn House Plot No. C 24 Sanath Nagar Industrial Estate Sanath N, Agar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of MSN Life Sciences Private Limited, buy the company report.
Comprehensive company report
MSN Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of MSN Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of MSN Life Sciences Private Limited, buy the company report.
Financials of MSN Life Sciences Private Limited
FY 2024 filings availableMSN Life Sciences Private Limited reported revenue of ₹1,961.87 Cr (up 54% YoY) for FY 2024.
Revenue · FY 2024
₹1,961.87 Cr ▲ 54%
Net profit · FY 2024
₹189.59 Cr margin 9.7%
EBITDA · FY 2024
₹399.58 Cr margin 20.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 14%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 60%
3 years · compounded
▲ 20%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 54% growth in the latest year. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹399.58 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹189.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.4% | ||||
| Net Profit Margin | 9.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of MSN Life Sciences Private Limited, buy the company report.
Board of directors of MSN Life Sciences Private Limited
MSN Life Sciences has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Reddy Manne | Director | 22 Apr 2013 | 13 Years 6 Months | Current |
| Sindhuja Reddy Manne Also directs: Rose Greenfields Private Limited, Laxmi Sindhuja Farms N Estates Private Limited, MLP Farms N Estates Private Limited and 5 more | Whole-Time Director | 01 Apr 2015 | 11 Years 6 Months | Current |
| Laxmi Prasuna Manne Also directs: MSN Urban Ventures LLP, MSN Facades LLP, Varenya Horticulture Private Limited and 5 more | Director | 22 Apr 2013 | 13 Years 6 Months | Current |
| Achyuth Reddy Manne Also directs: Varenya Horticulture Private Limited, Dakshayani Horticulture Private Limited, Janaka Green Meadows Private Limited and 5 more | Director | 01 Jun 2024 | 2 Years 4 Months | Current |
Peer comparison
MSN Life Sciences Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Centrient Pharmaceuticals India Private Limited | ₹2,240.1 Cr (FY 2025) | 8.0% | Toansa, Punjab, India | |||
| Unichem Laboratories Limited | ₹2,146.29 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Iol Chemicals and Pharmaceuticals Limited | ₹2,101.62 Cr (FY 2025) | -3.0% | Barnala, Punjab, India | |||
| Tianish Laboratories Private Limited | ₹2,059.53 Cr (FY 2024) | Hyderabad, Telangana, India | ||||
| Pfizer Healthcare India Private Limited | ₹1,981.45 Cr (FY 2025) | 4.0% | Chennai, Tamil Nadu, India | |||
| MSN Life Sciences Private Limitedthis company | ₹1,961.87 Cr (FY 2024) | ₹189.59 Cr | 9.7% | 54.0% | 1,960 | Hyderabad, Telangana, India |
| Hikal Limited | ₹1,864.8 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Aarti Pharmalabs Limited | ₹1,857.5 Cr (FY 2024) | -5.0% | Vapi, Gujarat, India | |||
| Morepen Laboratories Limited | ₹1,829.94 Cr (FY 2025) | 7.0% | Himachal Pradesh, India | |||
| MSN Pharmachem Private Limited | ₹1,716.51 Cr (FY 2024) | 40.0% | Hyderabad, Telangana, India |
To see the full peer comparison of MSN Life Sciences Private Limited, buy the company report.
Auditor
MSN Life Sciences Private Limited is audited by B.R.M. Reddy & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B.R.M. Reddy & Co. | FY 2023 | 0003247S |
Shareholding
The shareholding of MSN Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of MSN Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1,700.8 Cr
Satisfied charges
₹690.22 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Aug 2025 | 101151480 | State Bank of India | ₹250 Cr | Open | |
| 15 Oct 2024 | 100997838 | Hdfc Bank Limited | ₹200 Cr | Open | |
| 27 Feb 2024 | 100886302 | Others | ₹110 Cr | Open | |
| 14 Sep 2023 | 100786560 | Canara Bank | ₹150 Cr | Open | |
| 29 Aug 2023 | 100793288 | Citi Bank N.A. | ₹100 Cr | Open |
To see the full charge records of MSN Life Sciences Private Limited, buy the company report.
Total charge records: 27 View all charges
Deals & funding
MSN Life Sciences Private Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.64 Cr; the latest was in January 2012.
Total deals
5
Funding rounds
3
Secondary share transfers
2
Disclosed funding
₹1.64 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2012 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Jan 2008 | Funding round | ₹29.6 Lakh | Investors: 2 individuals |
| Oct 2007 | Funding round | ₹7 Lakh | Investors: an individual |
| Feb 2007 | Funding round | ₹1.27 Cr | Investors: 4 individuals |
| Mar 2006 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
MSN Life Sciences Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by M/S. Apithecary Pharma Private Limited. | Disposed |
To see the full case history of MSN Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
MSN Life Sciences Private Limited was last rated by Crisil on 26 Nov 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 26 Nov 2020 |
To see the full credit ratings and regulatory alerts of MSN Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for MSN Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
MSN Life Sciences has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Prathima Eggsel Private Limited | U05005TG1995PTC021411 |
To see the full group structure of MSN Life Sciences Private Limited, buy the company report.
Employees & EPFO
MSN Life Sciences Private Limited has a workforce of 1,960 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
1,960
Active EPFO establishments
1
Employee growth
21.74%
GST
MSN Life Sciences has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCV1325N1Z7 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of MSN Life Sciences Private Limited, buy the company report.
Recent activity
MSN Life Sciences Private Limited has 13 board changes on record since 2010: 4 appointments and 9 cessations. The latest: Achyuth Reddy Manne was appointed as Director on 01 Jun 2024.
Charges
A charge registered on 26 Dec 2022 via Charge ID 100670037 with Others was fully satisfied on 05 Dec 2025.
Charges
A charge registered on 30 Nov 2022 via Charge ID 100647733 with Others was fully satisfied on 17 Nov 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 200.00 Cr registered on 15 Oct 2024 with Charge ID 100997838 was modified on 16 Oct 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 110.00 Cr registered on 30 May 2022 with Charge ID 100577511 was modified on 25 Sep 2025.
Charges
A charge with State Bank Of India amounted to Rs. 250.00 Cr with Charge ID 101151480 was registered on 28 Aug 2025.
Charges
A charge with Others of Rs. 110.00 Cr registered on 27 Feb 2024 with Charge ID 100886302 was modified on 25 Feb 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 200.00 Cr with Charge ID 100997838 was registered on 15 Oct 2024.
AGM
Msn Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Canara Bank of Rs. 150.00 Cr registered on 14 Sep 2023 with Charge ID 100786560 was modified on 08 Aug 2024.
Charges
A charge with Citi Bank N.A. of Rs. 100.00 Cr registered on 29 Aug 2023 with Charge ID 100793288 was modified on 08 Aug 2024.
Charges
A charge with Citi Bank N.A. of Rs. 15.00 Cr registered on 29 Aug 2023 with Charge ID 100793279 was modified on 08 Aug 2024.
Appointed
Achyuth Reddy Manne was appointed as Director.
63 earlier events are in the company report.
News
Frequently asked questions
MSN Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 October 2005 (21+ years old) and is registered under CIN U24239TG2005PTC047655.
MSN Life Sciences has 4 current directors:
- Sindhuja Reddy Manne - Whole-Time Director
- Satyanarayana Reddy Manne - Director
- Laxmi Prasuna Manne - Director
- Achyuth Reddy Manne - Director
The latest financial statements of MSN Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of MSN Life Sciences is 36AACCV1325N1Z7, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of MSN Life Sciences is U24239TG2005PTC047655. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MSN Life Sciences has 1 court case on record: 1 filed against it.
MSN Life Sciences was incorporated on 03 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
MSN Life Sciences has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.64 Cr; the latest was in January 2012.
The peers of MSN Life Sciences by revenue are Centrient Pharmaceuticals India Private Limited, Unichem Laboratories Limited, Iol Chemicals and Pharmaceuticals Limited, Tianish Laboratories Private Limited, Pfizer Healthcare India Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Achyuth Reddy Manne was appointed as Director on 01 Jun 2024. Achyuth Reddy Manne ceased to be Additional Director on 01 Jun 2024. Chintapally Janardhan Reddy ceased to be Director on 15 Jul 2016. MSN Life Sciences has 13 board changes on record in total.
MSN Life Sciences can be reached through the website msnlabs.com. Its registered office is in Hyderabad, Telangana, India.